Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Meta-Analysis,Nutrition and Cancer

当前位置： X-MOL 学术 › Nutr. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Meta-Analysis
Nutrition and Cancer ( IF 2.9 ) Pub Date : 2024-01-18 , DOI: 10.1080/01635581.2023.2294522
Haoyu Wang _{1,

2} , Ruiyuan Yang ₁ , Cheng Cheng ₂ , Suyan Wang ₂ , Dan Liu ₁ , Weimin Li _{1,

2,

3}

Affiliation

The Glasgow Prognostic Score (GPS) has proven to be a good biomarker for lung cancer prognosis. However, its usefulness in lung cancer patients receiving checkpoint inhibitor immunotherapy remains ...

中文翻译：